"Faux-zempic" driving hospitalizations Experts warn against the risks of illegitimately obtained Ozempic and Wegovy Salon · Jan 17, 2024
3 Pharma Stocks for January 2024 Profits The pharmaceutical industry is thriving, fueled by steady demand for drugs, cost-efficient alternative discoveries, and rapid technological innovations. Hence, fundamentally strong pharma stocks Novo Nordisk (NVO), Eton Pharmaceuticals (ETON), and Pacira BioSciences (PCRX) might be profitable buys now. Read on…. StockNews.com · Jan 16, 2024
Will weight loss drugs kill the fast food business? Many firms see the dire forecasts as ‘overblown’ but they know they will have to adapt products to make ‘every bite counts’ The Guardian - UK · Jan 6, 2024
Ozempic and Wegovy Show Lower Risk of Suicidal Thoughts Hold onto your hats, folks, because there's some fascinating news in the world of diabetes and obesity drugs! A recent federal study found that people taki... Top News · Jan 5, 2024
People taking Wegovy and Ozempic have lower risk of suicidal thoughts vs. older drugs, study finds A new federal study finds that people taking popular diabetes and obesity drugs Ozempic and Wegovy had a lower risk of suicidal thoughts than those taking other medications to treat the same conditions The Independent UK · Jan 5, 2024
Eli Lilly Stock: Buy or Sell? Eli Lilly's diversified portfolio and high demand for its weight-loss drugs have pushed it to the top of Wall Street's list of top pharma stocks for 2024. Is now the time to buy? Barchart · Jan 4, 2024
Insulin Now Available for $35 a Month for Many Americans Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month. Kiplinger · Jan 3, 2024
The Guardian view on anti-obesity drugs: treating a disease that modernity made Editorial: Weight-loss drugs reveal that obesity is not a deep-seated aspect of character but something more contingent The Guardian - UK · Jan 1, 2024
FDA says watch out for fake Ozempic, a diabetes drug used by many for weight loss Thousands of fake units of the drug have been seized by the FDA, which is working alongside the manufacturer to test the counterfeit products for safety concerns. WEKU · Dec 23, 2023
FDA warns that counterfeit Ozempic is flooding US supply chain Officials have seized thousands of counterfeit units The Independent UK · Dec 23, 2023
FDA Seizes Thousands of Counterfeit Ozempic Shots for Diabetes Counterfeit Ozempic diabetes drug seized by FDA, prompting concerns over identity, quality, and safety. Report suspect packages to FDA hotline. Top News · Dec 22, 2023
'I had to set two alarms at night to check my glucose to make sure I wouldn’t die': meet the revolutionary who won't stop until cycling is safer The UCI banned his technology from races, yet Supersapiens boss Phil Southerland tells Chris Marshall-Bell he is still dead set on changing the sport in the most profound way for decades Cycling Weekly · Dec 16, 2023
Weight loss from Lilly’s Zepbound drug reversed after stopping treatment, according to study ‘They gain back about half the weight they had originally lost over a one-year period of time,’ professor says The Independent UK · Dec 12, 2023
Chasing Weight Loss Dream, Many In US Seek Ozempic Alternatives Like many Americans struggling to lose weight, Marissa Montanino felt compelled to try Ozempic or one of the other new so-called "wonder drugs" described as revolutionary in the fight against obesity. International Business Times · Dec 4, 2023
Fortune · Nov 27, 2023 Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs Weight-loss drug Wegovy faces high demand, limited supply, and tricky health care systems to navigate.
Barchart · Nov 24, 2023 3 Buy-Rated Healthcare Dividend Stocks for Income Investors Looking for analysts' favorite stock picks in a traditionally defensive sector, with solid dividend payments to help boost your returns? Here's a look at three stocks for income investors to consider at current levels.
The Guardian - UK · Nov 18, 2023 Revealed: obesity jab maker discussed targeting benefit claimants with UK government Drug firm Novo Nordisk proposed singling out those most likely to return to work with its weight-loss injection
Fortune · Nov 16, 2023 Germany considers banning Ozempic exports, including to U.S. Germany exports Ozempic to the EU and the U.S., Karl Broich, president of the German Federal Institute for Drugs and Medical Devices, told Der Spiegel.
Fortune · Nov 13, 2023 Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports Wegovy was found to cut the risk of serious heart events by 20%—Novo Nordisk has now asked the U.S. FDA to reflect the heart benefits in the drug's label.
The Independent UK · Nov 11, 2023 Obesity drug Wegovy cut risk of serious heart problems by 20%, study finds A new large study finds that the popular weight-loss drug Wegovy reduced the risk of serious heart problems by 20% in certain patients
Fortune · Nov 9, 2023 Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug U.S. regulators signed off on Eli Lilly’s diabetes drug Zepbound, which can also be used to aid weight loss like Wegovy and Ozempic.
The Guardian - UK · Nov 9, 2023 AstraZeneca makes big push into weight-loss market with obesity pill deal UK drugmaker signs agreement with China’s Eccogene to work on an obesity and type 2 diabetes pill
Fortune · Nov 6, 2023 Novo Nordisk threatens to expand in US in row over EU rules Novo Nordisk's CEO doesn't like proposed new EU rules that would cut the period for which drugmakers enjoy exclusivity for their products from 10 years to eight years.
Fortune · Nov 2, 2023 Novo Nordisk gives foodmakers $900 million reason to worry Sales would have been higher if not for a shortfall following surging demand.
The Guardian - UK · Nov 2, 2023 Sales soar at Danish firm behind weight-loss drug semaglutide Novo Nordisk says it struggling to keep up with demand after becoming Europe’s most valuable company